Skip to Main Content

Paper Details

A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.
J Am Soc Nephrol
145
2017
B cells, CKD, IgA, IgA Nephropathy, IgA nephropathy, Proteinuria, Renal Dysfunction, Rituximab, angiotensin receptor, angiotensin-converting enzyme, antibody, antibody-producing B cells, antigalactose-deficient IgA1 antibodies, creatinine, galactose, galactose-deficient IgA1, patients, proteinuria, rituximab
Author NameAffiliation
Brad H RovinOhio State University
Brad H RovinOhio State University
James A TumlinUniversity of Tennessee
Felicity T EndersMayo Clinic
  • 1 - 4

Datasets

Release 1.2